Company / Income Tax
Catalyst Pharmaceuticals Partners, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$69.2M
FY2025
5-year range
$13.2M / $69.2M
FY2021-FY2025
Trend
+32.1%
vs FY2024
Sector context
#22 of 204
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s income tax of $69M is higher than 89% of companies in the Health Care sector (FY2025). Income Tax has increased for 5 consecutive years, from -$33M in FY2020 to $69M in FY2025.
Based on SEC 10-K filings.
$69M in FY2025 with a 3-year CAGR of +47.3%. Top quartile in the Health Care sector.
Increased from $23M to $69M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +47.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 204This company $69.2M Sector average $118.7M
▼
-41.7% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s income tax has grown for 5 consecutive years.
- 3-year CAGR of +47.3%, indicating consistent growth.
- In FY2025, income tax increased 32.1% year-over-year.
- Ranks #22 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $69.2M | +32.1% |
| FY2024 | $52.4M | +126.7% |
| FY2023 | $23.1M | +6.8% |
| FY2022 | $21.6M | +64.1% |
| FY2021 | $13.2M | +139.8% |
| FY2020 | -$33.1M | -2257.3% |
| FY2019 | $1.5M | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026